NEW YORK – Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the promotions of Michael Golembiewski to Chief Financial Officer and Anthony Marciano to Chief Communications Officer, each effective September 1, 2021. “I...
people News
Mintpellier, France — SeqOne Genomics, provider of next generation genomic analysis solutions for personalized medicine, announces the appointment of Hervé Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the company to accelerate its growth and strengthen its international presence.Hervé has more than 25 years of...
MUNCIE — Christopher Burrows got the best possible treat last Halloween. That’s the day he and his mother, Claudia Burrows, brought home Stitch, the service dog they’d been working toward for the past year. Claudia has ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease, while Christopher has autism...
It’s a warm Tuesday afternoon and the Shalvey family is enjoying the sun out on their patio while their dogs, Sam and Jerry, run around the yard. Add in their white picket fence and the image is idyllic – but not uncommon for Bill and Lynne and their two daughters,...
CLONMEL, Ireland – Shorla Pharma Limited (‘Shorla’), a specialty pharmaceutical company, announces the appointment of Chief Commercial Officer Nicholas Holsman, a highly experienced U.S. industry executive with in-depth experience in scaling oncology & specialty pharma enterprises. Shorla specializes in developing innovative oncology drugs, with a focus on orphan and pediatric cancers....
Imagine glass shards being smashed relentlessly into your bones over and over again. That is what the pain of sickle cell disease feels like, a young girl once told Velvet Brown-Watts, who three years ago started a local support group for sickle cell patients and their families. “I thought that...
REHOVOT and RAMAT GAN , Israel — Skip Therapeutics developer of computational platform for design of Antisense Oligonucleotide (ASO) based therapies and Sheba Medical Center, one of the leading medical centers in the world, announced today that they have entered a collaboration for the development of ASO-based treatments for rare...
WELLAND — While 12-year-old Andrew Lanese hasn’t been well enough to attend St. Alexander Catholic School, his fellow students and staff still consider him to be a part of their team that went out on the soccer fields Tuesday. The school hosted the first, of what is hoped to become...
He is just eight years old and should be enjoying football and computer games. But Ben Scott suffers from a rare form of dementia – which is slowly robbing him of his mental faculties and taking his life away. He can still recognise his mum and dad and give them...
WATERTOWN, Mass. — Sonata Therapeutics, a biotechnology company developing a new class of therapeutics called Network Medicines™, and the Champalimaud Foundation, a world leader in biomedical research and academic medicine, today announced a research collaboration for the development of Sonata’s novel Network Medicine, SNT-3012. The partnership will drive the continued...